What is CaNCURE?

CaNCURE was created in 2015 to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Sixty-six trainees have already completed the program so far, and we expect to train another eighty-nine students in the next 5 years.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research laboratory.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.









Hear from our Alumni:

“CaNCURE has helped to firm my interest in cancer medicine because it taught me the actual science behind a disease that presents itself in so many different ways. I love interacting with the cancer patients in our clinic because they are so humble and really teach me about taking life one day at a time.”

Marisa Wozniak, CaNCURE ’16

Trainee Spotlight

Esteban Enrique

Biochemistry, '20

Assessing sufficiency of the Tip60/p400 complex in inducing transcription of Merkel Cell Polyomavirus Small T antigen target genes.

Anthony Alvarez

Health Sciences, '20

Targeted Delivery of Talazoparib to Treat Non-Small Cell Lung Cancer

Abigail Cohen

Health Sciences, '20

In Vivo Treatment of Established HGSOC Line Using Novel Therapy

Featured Trainee Publication

Upcoming Events

Check back soon for new events

Mentor Spotlight

Tracy Batchelor, M.D.

Executive Director, Stephen E. and Catherine Pappas Center for Neuro-Oncology,

Develops novel therapeutics for malignant primary brain tumors. Students will have the opportunity to image and characterize tumor markers of sensitivity and resistance to anti-angiogenic therapeutics, with the goal of defining and exploiting alternative pro-angiogenic targets.

Zdravka Medarova, Ph.D.

Associate Professor in Radiology, MGH/MIT/HMS

The focus of my research has been the development and testing of multi-functional imaging/delivery vehicles for combined cancer imaging and therapy. More recently, our lab developed magnetic nanoparticles as delivery vehicles of miRNA-targeted therapy to breast tumors.

Trainee Spotlight

Kaylie DeCosmo

Health Sciences, '20

Nanoparticle-aided radio-immunotherapy

Alyssa Lam

Health Sciences, '20

Detection of low-level mutations in DNA obtained from cancer patients, using PCR and nano-PCR

Jessica Munck

Behavioral Neuroscience, '20

Assessment of atherosclerotic changes following neoadjuvant therapy using ferumoxytol as contrast imaging agent

 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 9 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in September 2018 via NUcareers.

Going on in the lab right now...